Related Experiment Video
Updated: Aug 13, 2026

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
Purification and characterization of a novel soluble receptor for interleukin 1
J A Symons1, J A Eastgate, G W Duff
1Department of Medicine and Pharmacology, University of Sheffield, Royal Hallamshire Hospital, United Kingdom.
Insights
Researchers purified a soluble interleukin-1 beta (IL-1 beta) binding protein from human B cells. This protein specifically binds IL-1 beta and may regulate its activity in vivo.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Interleukin-1 beta (IL-1 beta) is a key inflammatory cytokine.
- Understanding IL-1 beta regulation is crucial for controlling inflammatory diseases.
- Soluble forms of receptors can modulate cytokine activity.
Purpose of the Study:
- To purify and characterize a soluble IL-1 beta binding protein from Raji B cells.
- To investigate the binding properties and specificity of the purified protein.
- To assess the potential regulatory role of this soluble protein in IL-1 beta signaling.
Main Methods:
- Affinity chromatography and reverse-phase high-performance liquid chromatography (HPLC) for protein purification.
- Radioligand binding assays using 125I IL-1 beta.
- Ligand blotting and competitive binding assays.
- Measurement of binding affinities (Kd) for cell surface and soluble IL-1 receptors.
Main Results:
- A soluble IL-1 beta specific binding protein was purified from Raji cell supernatant.
- The purified protein formed complexes with IL-1 beta under reducing and non-reducing conditions.
- Binding was specific for IL-1 beta and its propeptide, but not IL-1 alpha or IL-1 receptor antagonist.
- The soluble IL-1 receptor (sIL-1R) exhibited similar binding affinity to IL-1 beta as the cell surface IL-1R.
- Purified sIL-1R inhibited IL-1 beta binding to both type I and type II IL-1 receptors.
Conclusions:
- A novel soluble IL-1 beta binding protein (sIL-1R) was identified and characterized.
- This sIL-1R specifically binds IL-1 beta and can inhibit its interaction with cell surface receptors.
- The findings suggest that this natural sIL-1R plays a significant role in regulating IL-1 beta activity in vivo.
Abstract:
Affinity chromatography and reverse-phase high-performance liquid chromatography was used to purify a soluble interleukin 1 beta (IL-1 beta) specific binding protein from the supernatant of a human B cell line, Raji. The purified protein specifically bound 125I IL-1 beta forming a 60-kD complex in nonreducing conditions and a 70-kD complex in reducing conditions. Binding was found to be displaceable by mature human and murine IL-1 beta and human 31-kD IL-1 beta propeptide, but not displaceable by human and murine IL-1 alpha or human IL-1 receptor (IL-1R) antagonist. Ligand blotting revealed a 47-kD molecule that specifically bound IL-1 beta. Measurement of binding affinity of the cell surface Raji IL-1R (Kd = 2.2 nm) and the Raji soluble (s)IL-1R (Kd = 2.7 nm) demonstrated a similar affinity for 125I IL-1 beta. Purified sIL-1R inhibited binding of IL-1 beta to cell lines with both type I (80 kD) and type II (65 kD) IL-1Rs, but did not interfere with IL-1 alpha binding. This natural sIL-1R may function as an important regulatory molecule of IL-1 beta in vivo.

